186 related articles for article (PubMed ID: 21052571)
21. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
Chan CC; Rodger IW
Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
[No Abstract] [Full Text] [Related]
22. The mechanism of action of anti-inflammatory drugs.
Vane JR
Ernst Schering Res Found Workshop; 2000; (31):1-23. PubMed ID: 10943325
[No Abstract] [Full Text] [Related]
23. [Pharmacology of cyclooxygenase 2 inhibition].
Beubler E
Wien Med Wochenschr; 2003; 153(5-6):95-9. PubMed ID: 12705061
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD
Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897
[TBL] [Abstract][Full Text] [Related]
25. [Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor].
Bennett A; Vila D
Vutr Boles; 2000; 32(1):33-6. PubMed ID: 11195195
[TBL] [Abstract][Full Text] [Related]
26. Arthropathy in art and the history of pain management--through the centuries to cyclooxygenase-2 inhibitors.
Appelboom T
Rheumatology (Oxford); 2002 Apr; 41 Supp 1():28-34. PubMed ID: 12173278
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
28. A seven-step plan for becoming a moderately rich and famous biochemist.
Smith WL
J Biol Chem; 2019 Feb; 294(6):1779-1793. PubMed ID: 30737317
[TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal antiinflammatory drugs: benefits, risks, and COX-2 selectivity.
Halverson PB
Orthop Nurs; 1999; 18(6):21-6; quiz 27-8. PubMed ID: 11062611
[TBL] [Abstract][Full Text] [Related]
30. [A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs].
Pasero G; Marson P
Reumatismo; 2011; 63(2):111-23. PubMed ID: 21776448
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
Meyer-Kirchrath J; Schrör K
Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
[TBL] [Abstract][Full Text] [Related]
32. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
33. [History of coxibs, precariousness of certainties].
Bouvenot G
Presse Med; 2002 Sep; 31(31):1444-5. PubMed ID: 12395733
[No Abstract] [Full Text] [Related]
34. [World-wide sales power of a drug group! The evolution of antipyretic analgesics].
Brune K; Egger T
Pharm Unserer Zeit; 2002; 31(2):133-9. PubMed ID: 11977448
[No Abstract] [Full Text] [Related]
35. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.
Grösch S; Niederberger E; Geisslinger G
Expert Opin Investig Drugs; 2017 Jan; 26(1):51-61. PubMed ID: 27841017
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
Cryer B; Feldman M
Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023
[TBL] [Abstract][Full Text] [Related]
37. Ginger--an herbal medicinal product with broad anti-inflammatory actions.
Grzanna R; Lindmark L; Frondoza CG
J Med Food; 2005; 8(2):125-32. PubMed ID: 16117603
[TBL] [Abstract][Full Text] [Related]
38. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
Celotti F; Durand T
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
[TBL] [Abstract][Full Text] [Related]
39. Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use.
Cashman J; McAnulty G
Drugs; 1995 Jan; 49(1):51-70. PubMed ID: 7705216
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.
Umar A; Steele VE; Menter DG; Hawk ET
Semin Oncol; 2016 Feb; 43(1):65-77. PubMed ID: 26970125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
